Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 15488813.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To report control of intravitreal triamcinolone acetonide-induced elevated intraocular pressure (IOP) by vitrectomy-assisted corticosteroid removal. Interventional case series. Of the 26 eyes that had intravitreal injection of triamcinolone acetonide for various causes, 11 eyes (42.5%) developed elevated IOP. In nine eyes IOP was controlled by antiglaucoma medication. Two eyes of two patients developed uncontrolled IOP despite maximal antiglaucoma medication. These eyes underwent vitrectomy and removal of triamcinolone acetonide. IOP returned to normal in 3 weeks and 1 week, respectively, after vitrectomy. Elevated IOP associated with intravitreal injection of triamcinolone acetonide that is not controlled by maximal antiglaucoma medication can be effectively treated by vitrectomy-assisted removal of triamcinolone acetonide.
Medical subject headings
- Glucocorticoids
- Intraocular Pressure
- Ocular Hypertension
- Triamcinolone Acetonide
- Vitrectomy